Heather A. Hirsch, Ph.D., et al. Genomics based studies of gastric tumors identify ICOS as potential target for therapeutic intervention. Presented at AACR Annual Meeting, April 16, 2018.
Contact Us
Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge, MA 02139
Phone: (857) 259-3840
Fax: (888) 459-2940
For Investor and Media inquiries, please contact:
Eric Laub
(857) 259-3853 elaub@jouncetx.com